On February 6, 2023 Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, reported that it will release financial results for the fourth quarter and full year of 2022 after the market close on Monday, March 6th, 2023 (Press release, Akoya Biosciences, FEB 6, 2023, View Source [SID1234626855]). Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the "Investors" section of the Akoya website at View Source

Akoya also announced that Brian McKelligon, CEO, will be participating in two upcoming investor conferences.

BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

43rd Annual Cowen Healthcare Conference
Tuesday, March 7th at 2:10 p.m. ET
A live webcast of the 43rd Annual Cowen Healthcare Conference will be available on the "Investors" section of the Akoya website View Source